Showing results (101-110 of 123) with videos related to
Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|January 1, 1985
Human pharmacokinetics of marcellomycinP Dodion, M Rozencweig, C Nicaise, et al.European Journal of Cancer & Clinical Oncology|February 1, 1983
Phase II trial of diaziquone (AZQ) in advanced malignant melanomaH Høst, R Joss, H Pinedo, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanomaP Alberto, M Rozencweig, M Clavel, et al.Cancer Treatment Reports|November 1, 1979
Analysis and interpretation of response rates for anticancer drugsY J Lee, R Catane, M Rozencweig, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1993
Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS or AIDS-related complexM Beltangady, C A Knupp, N Gustafson, et al.Investigational New Drugs|January 1, 1985
Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC)E E Holdener, H H Hansen, H Høst, et al.Reviews of Infectious Diseases|July 1, 1990
Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patientsM Rozencweig, C McLaren, M Beltangady, et al.European Journal of Cancer & Clinical Oncology|April 1, 1983
Clinical phase I trial of marcellomycin with a single-dose scheduleC Nicaise, M Rozencweig, M de Marneffe, et al.European Journal of Cancer & Clinical Oncology|February 1, 1984
Phase II study of 9-hydroxy-2N-methylellipticinium acetateA Clarysse, A Brugarolas, P Siegenthaler, et al.Cancer|September 15, 1988
Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A Phase II Study of the EORTC Malignant Melanoma Cooperative GroupC F Verschraegen, U R Kleeberg, J Mulder, et al.Pageof 13